CING
Price
$3.33
Change
-$0.47 (-12.37%)
Updated
Nov 13 closing price
Capitalization
18.67M
Intraday BUY SELL Signals
ELVN
Price
$20.27
Change
-$0.03 (-0.15%)
Updated
Nov 13 closing price
Capitalization
1.2B
118 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CING vs ELVN

Header iconCING vs ELVN Comparison
Open Charts CING vs ELVNBanner chart's image
Cingulate
Price$3.33
Change-$0.47 (-12.37%)
Volume$381.91K
Capitalization18.67M
Enliven Therapeutics
Price$20.27
Change-$0.03 (-0.15%)
Volume$459.69K
Capitalization1.2B
CING vs ELVN Comparison Chart in %
CING
Daily Signal:
Gain/Loss:
ELVN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CING vs. ELVN commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a Hold and ELVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CING: $3.33 vs. ELVN: $20.27)
Brand notoriety: CING and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 193% vs. ELVN: 83%
Market capitalization -- CING: $18.67M vs. ELVN: $1.2B
CING [@Biotechnology] is valued at $18.67M. ELVN’s [@Biotechnology] market capitalization is $1.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 1 FA rating(s) are green whileELVN’s FA Score has 1 green FA rating(s).

  • CING’s FA Score: 1 green, 4 red.
  • ELVN’s FA Score: 1 green, 4 red.
According to our system of comparison, both CING and ELVN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 3 TA indicator(s) are bullish while ELVN’s TA Score has 5 bullish TA indicator(s).

  • CING’s TA Score: 3 bullish, 6 bearish.
  • ELVN’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than CING.

Price Growth

CING (@Biotechnology) experienced а -9.51% price change this week, while ELVN (@Biotechnology) price change was +10.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

ELVN is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.2B) has a higher market cap than CING($18.7M). ELVN YTD gains are higher at: -9.911 vs. CING (-32.454). CING has higher annual earnings (EBITDA): -17.21M vs. ELVN (-113.93M). ELVN has more cash in the bank: 491M vs. CING (8.9M). ELVN has less debt than CING: ELVN (580K) vs CING (6.58M). CING (0) and ELVN (0) have equivalent revenues.
CINGELVNCING / ELVN
Capitalization18.7M1.2B2%
EBITDA-17.21M-113.93M15%
Gain YTD-32.454-9.911327%
P/E Ratio0.02N/A-
Revenue00-
Total Cash8.9M491M2%
Total Debt6.58M580K1,135%
TECHNICAL ANALYSIS
Technical Analysis
CINGELVN
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CING
Daily Signal:
Gain/Loss:
ELVN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FATIX157.69N/A
N/A
Fidelity Advisor Technology I
MCMVX21.17-0.39
-1.81%
Monongahela All Cap Value
GWGZX19.54-0.38
-1.91%
AMG GW&K Small Mid Cap Core Z
OCLGX15.38-0.37
-2.35%
Optimum Large Cap Growth C
BGFRX14.02-0.34
-2.37%
William Blair Growth R6

CING and

Correlation & Price change

A.I.dvisor indicates that over the last year, CING has been loosely correlated with ABCL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CING jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
-12.37%
ABCL - CING
34%
Loosely correlated
-8.82%
RXRX - CING
30%
Poorly correlated
-6.88%
BEIGF - CING
29%
Poorly correlated
N/A
GOVX - CING
29%
Poorly correlated
-5.80%
ELVN - CING
29%
Poorly correlated
-0.15%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with NUVL. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-0.15%
NUVL - ELVN
55%
Loosely correlated
-2.42%
DNLI - ELVN
52%
Loosely correlated
-2.11%
SYRE - ELVN
52%
Loosely correlated
-3.41%
CRNX - ELVN
50%
Loosely correlated
-3.25%
APGE - ELVN
50%
Loosely correlated
-0.21%
More